At one month post-1st booster, patients with negative antibodies (below the threshold of 9.1 IU/mL) included one case of Hyper-IgM, two of CVID, one of XLA and one of Combined Immunodeficiency. This evidence concerns the gene CD40LG and severe combined immunodeficiency.